Form D · Biotechnology
Seraxis Holdings, Inc.
Germantown, MD · CIK 0001845486
Offering snapshot reported Sep 24, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 7, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2026 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Feb 23, 2021 | Initial | $14,000,011 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598789
Source: Form D, filed Sep 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roy Arup | Director |
| Jerry Baty | Director |
| William L. Rust | Director, Executive |
| James N. Topper | Director |
| Bernie Treidl | Director |
| Carole Welsch | Executive |
| Gi Hyeok Yang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20400 Century Boulavard Suite 150
Germantown, MD, 20874
Phone: 240-780-8064
Germantown, MD, 20874
Phone: 240-780-8064